SRDX – Doubts about the ophthalmic collaboration with MRK have kept me from owning this stock for the past few years. However, the share price (in AH trading) is now down more than 40% from its 12-month high.
Due to the lower valuation, I’m putting SRDX back on my watch list for a possible long position.
Market Data 
Markets 
AI
